Title : Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.

Pub. Date : 2021 Feb

PMID : 33387788






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2. Dexamethasone angiotensin converting enzyme 2 Homo sapiens
2 Molecular docking results revealed that DEX occupied with active binding site of ACE2 of SARS-CoV-2 spike protein. Dexamethasone angiotensin converting enzyme 2 Homo sapiens
3 Surface plasmon resonance (SPR) results showed that KD value between DEX and ACE2 was (9.03 +- 0.78) e-6 M. Cell membrane chromatography (CMC) results uncovered that DEX had a chromatographic retention. Dexamethasone angiotensin converting enzyme 2 Homo sapiens
4 Surface plasmon resonance (SPR) results showed that KD value between DEX and ACE2 was (9.03 +- 0.78) e-6 M. Cell membrane chromatography (CMC) results uncovered that DEX had a chromatographic retention. Dexamethasone angiotensin converting enzyme 2 Homo sapiens
5 DEX was found out to inhibiting the viropexis into ACE2h cells using SARS-CoV-2 spike pseudotyped virus. Dexamethasone angiotensin converting enzyme 2 Homo sapiens
6 Therefore, DEX inhibits the entrance of SARS-CoV-2 spike pseudotyped virus into cell by binding to ACE2. Dexamethasone angiotensin converting enzyme 2 Homo sapiens